GASTROGRAFFIN USE IN DISTAL INTESTINAL OBSTRUCTION SYNDROME OF CYSTIC FIBROSIS

Authors

  • Uzma Shah
  • Yasir Shafiq
  • Muhammad Arif Mateen Khan

Abstract

Background: Meconium ileus equivalent or the Distal Intestinal Obstruction Syndrome (DIOS) isan entity that is frequently seen in patients with cystic fibrosis (CF). In the gastrointestinal tractcystic fibrosis may produces symptoms of malabsorption and constipation. The latter may beassociated with complications such as impaction and intestinal perforation. Meconium ileus andDIOS are an emergency and requires to be treated aggressively to ensure that consequences suchas perforation do not occur. Method: Traditional modes of management of DIOS have includedthe use of laxatives, Acetylcysteine and Gastrograffin enemas. We are describing the use of oralgastrograffin in our patient seen at the Aga Khan University Hospital where small bowelobstruction was refractory to treatment. Oral gastrograffin was used once diluted in 4 times thevolume of water or fruit juice with half doses given on day 2 and 3. Results: Oral gastrograffinuse was followed by relief of obstruction in this patient. Conclusion: Gastrograffin use orally orrectally may be helpful in the treatment of refractions distal intestinal obstruction syndrome incystic fibrosis.Keyword: Gastrograffin, Intestinal, Syndrome, Cystic fibrosis

References

Rubinstein S, Moss R, Lewiston N. Constipation and

meconium ileus equivalent in patients with cystic fibrosis.

Pediatrics 1986;78(3):473-79.

Millar-Jones L, Goodchild MC. Cystic Fibrosis, pancreatic

sufficiency and distal intestinal obstruction syndrome: a

report of four cases. Acta Paediatr 1995;84(5):577-78

Khoshoo V, Udall JN Jr. Meconium ileus equivalent in

children and adults.Am J Gastroenterol 1994;89(2):153-57

Andersen HO, Hjelt K, Waever E, Overgaard K. The age -

related incidence of meconium ileus equivalent in a cystic

fibrosis population: the impact of high-energy intake. J

Pediatr Gastroenterol Nutr 1990;11(3):356-60

Dray X, Bienvenu T, Desmazes-Dufue N, Dusser D, Marteau

P, Hubert D. Distal Intestinal Obstruction Syndrome in

Adults with Cystic Fibrosis. Clin Gastroenterol Hepatol

;2(6):498-503.

Koletzko S, Stringer DA, Cleghorn GJ, Durie PR. Lavage

treatment of distal intestinal obstruction syndrome in children

with cystic fibrosis. Pediatrics 1989;83(5):727-33

Shah A, Madge S, Dinwiddie R, Habibi P. Hypoglycemia

and Golytely in distal intestinal obstruction syndrome. J R

Soc Med. 1994; 87(2):109-10

Burke MS, Ragi JM, Karamanoukian HL, Kotter M, Brisseau

GF, Borowitz DS et al. New strategies in nonoperative

management of mecoinum ileus. J Pediatr Surg.

;37(5):760-4.

Kao SC, Franken EA. Nonoperative treatment of simple

meconium ileus: a survey of the Society for Pediatric

Radiology.Pediatr Radiol. 1995;25(2):97-100.

Zentler-Munro PL. Cystic fibrosis--a gastroenterological

cornucopia. Gut. 1987;28(11):1531-47.

Hypaque package insert (Winthrop, US). In: PDR Physicians'

desk reference. 36th ed. 1982. Oradell, NJ: Medical

Economics Company, 1982: 3019, 3043-59.

McEvoy GK, editor. AHFS Drug information 91. Bethesda,

MD: American Society of Hospital Pharmacists, 1991: 858,

Cohen MD. Choosing contrast media for pediatric

gastrointestinal examinations. Crit Rev Diagn Imaging 1990;

(4): 317-40.

Poole CA, Rowe MI. Clinical evidence of intestinal

absorption of Gastrografin. Radiology. 1976; 118(1): 151-3.

Swanson DP, Chilton HM, Thrall JH, editors.

Pharmaceuticals in medical imaging. New York: Macmillan

Publishing Company, 1990: 1-35, 42, 95-97, 166, 253-77.

Manufacturer Drug Information. Hypaque Meglumine 30%

package insert (Winthrop-US), Rev 4/89.

Manufacturer Drug Information. Hypaque sodium oral

solution package insert (Sanofi Winthrop-US), Rev 6/92, Rev

/93.

O'Halloran SM, Gilbert J, McKendrick OM, Carty HM, Heaf

DP. Gastrografin in acute meconium ileus equivalent. Arch

Dis Child. 1986; 61(11):1128-30.

Published

2007-03-01

Issue

Vol. 19 No. 1 (2007): JOURNAL OF AYUB MEDICAL COLLEGE, ABBOTTABAD

Section

CASE REPORT

License

Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License  CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.

USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.